Summary
ImmunoCellular Therapeutics, Ltd. (IMCU) is a clinical-stage biotechnology company. It develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product pipeline comprises ICT-107, ICT-140 and ICT-121. ICT-107, the lead product candidate of the company is being developed for the treatment of glioblastoma multiforme (GBM); ICT-140, a DC vaccine designed to treat recurrent ovarian cancer; and ICT-121 for the treatment of recurrent GBM and other solid tumors. The company is also developing stem cell therapies for treating cancer. As of March 2015, the development of ICT-140 has been put on hold. IMCU is headquartered in Calabasas, California, the US.
ImmunoCellular Therapeutics, Ltd. (IMUC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
ImmunoCellular Therapeutics, Ltd., Medical Devices Deals, 2010 to YTD 2016 9
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 12
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 13
ImmunoCellular Therapeutics Enters into Agreement with Canadian Brain Tumour Consortium 14
ImmunoCellular Therapeutics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 15
ImmunoCellular Therapeutics Enters into Agreement with Pure MHC 16
BioWa Forms Joint Venture With Immunocellular 17
Licensing Agreements 18
ImmunoCellular Therapeutics Enters into Licensing Agreement with California Institute of Technology 18
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 19
ImmunoCellular Enters Into Licensing Agreement With Johns Hopkins University For Mesothelin Cancer Antigen 20
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 22
ImmunoCellular Therapeutics Enters Into Licensing Agreement With BioWa 23
Roche Terminates Option Licensing Agreement With ImmunoCellular Therapeutics 24
ImmunoCellular Therapeutics Enters Into Licensing Agreement With Targepeutics 25
Equity Offering 26
ImmunoCellular Therapeutics Raises USD16 Million in Public Offering of Shares and Warrants 26
ImmunoCellular Therapeutics Decreases Size Of Public Offering Of Shares For US$17 Million 28
ImmunoCellular Therapeutics Completes Public Offering Of Shares For US$21 Million 29
ImmunoCellular Therapeutics Completes Public Offering Of Units For US$10.4 Million 31
ImmunoCellular Therapeutics Completes Private Placement For US$8 Million 32
ImmunoCellular Therapeutics Completes Private Placement Of US$4 Million 34
ImmunoCellular Therapeutics, Ltd. - Key Competitors 36
Key Employees 37
Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Key Facts, 2014 1
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ImmunoCellular Therapeutics, Ltd., Deals By Therapy Area, 2010 to YTD 2016 8
ImmunoCellular Therapeutics, Ltd., Medical Devices Deals, 2010 to YTD 2016 9
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 12
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 13
ImmunoCellular Therapeutics Enters into Agreement with Canadian Brain Tumour Consortium 14
ImmunoCellular Therapeutics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 15
ImmunoCellular Therapeutics Enters into Agreement with Pure MHC 16
BioWa Forms Joint Venture With Immunocellular 17
ImmunoCellular Therapeutics Enters into Licensing Agreement with California Institute of Technology 18
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 19
ImmunoCellular Enters Into Licensing Agreement With Johns Hopkins University For Mesothelin Cancer Antigen 20
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 22
ImmunoCellular Therapeutics Enters Into Licensing Agreement With BioWa 23
Roche Terminates Option Licensing Agreement With ImmunoCellular Therapeutics 24
ImmunoCellular Therapeutics Enters Into Licensing Agreement With Targepeutics 25
ImmunoCellular Therapeutics Raises USD16 Million in Public Offering of Shares and Warrants 26
ImmunoCellular Therapeutics Decreases Size Of Public Offering Of Shares For US$17 Million 28
ImmunoCellular Therapeutics Completes Public Offering Of Shares For US$21 Million 29
ImmunoCellular Therapeutics Completes Public Offering Of Units For US$10.4 Million 31
ImmunoCellular Therapeutics Completes Private Placement For US$8 Million 32
ImmunoCellular Therapeutics Completes Private Placement Of US$4 Million 34
ImmunoCellular Therapeutics, Ltd., Key Competitors 36
ImmunoCellular Therapeutics, Ltd., Key Employees 37
ImmunoCellular Therapeutics, Ltd., Subsidiaries 38
List of Figures
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ImmunoCellular Therapeutics, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
ImmunoCellular Therapeutics, Ltd., Medical Devices Deals, 2010 to YTD 2016 9
